Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enovix Corporation (ENVX) SEC filings page on Stock Titan provides access to the company’s official U.S. regulatory documents, along with AI-powered summaries to help interpret complex disclosures. As a Nasdaq-listed battery technology company focused on advanced lithium-ion cells and 100% active silicon-anode architectures, Enovix uses its SEC reports to describe financial performance, capital structure, risk factors and material events.
Through this page, you can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Enovix’s business model, battery technology, manufacturing footprint in regions such as Malaysia and South Korea, and markets including smartphones, smart eyewear, IoT, industrial and defense applications. Our AI tools highlight key sections, such as revenue trends, operating expenses, liquidity, and the Risk Factors and MD&A discussions referenced in the company’s press releases.
You can also follow current reports on Form 8-K, where Enovix has disclosed items such as quarterly financial results, a warrant dividend distribution, authorization of a share repurchase plan, and the issuance of 4.75% Convertible Senior Notes due 2030 with related capped call transactions. These filings explain terms of the notes, conversion conditions, redemption provisions and the intended use of proceeds, including potential acquisitions in the battery ecosystem.
In addition, this page surfaces registration statements, prospectus supplements and related exhibits that describe the warrant program (ENVXW), share issuance mechanics and legal opinions, as well as any future Form 4 insider transaction reports when available. AI-generated overviews help clarify technical language, summarize covenant and event-of-default provisions, and point out changes in capital structure or share count. Together, these tools allow investors to navigate Enovix’s regulatory history more efficiently while still relying on the underlying SEC documents as the authoritative source.
Enovix Corp’s Chief Accounting Officer, Kristina Truong, reported a routine tax-related share withholding. On January 5, 2026, 697 shares of Enovix common stock were withheld at $8.73 per share to satisfy tax obligations tied to the vesting of restricted stock units (RSUs).
After this transaction, Truong beneficially owns 196,051 shares of Enovix common stock. This amount includes 147,679 shares issuable upon future RSU vesting and 4,978 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each performance RSU converts into one share upon settlement.
Enovix Corp's Chief Legal Officer, Arthi Chakravarthy, reported an automatic share withholding tied to equity compensation. On December 24, 2025, 2,217 shares of Enovix common stock were withheld at $8.27 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs). After this transaction, Chakravarthy beneficially owned 418,228 shares, including 297,316 shares issuable upon future RSU vesting and 20,786 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half scheduled for release on March 1, 2027, each representing the right to receive one share of Enovix common stock.
Enovix Corp officer Kristina Truong, the Chief Accounting Officer, reported a routine equity transaction on December 13, 2025 related to restricted stock vesting.
The filing shows 1,013 shares of common stock were withheld at $ 8.64 per share to satisfy tax withholding obligations when her restricted stock units vested. After this, she beneficially owned 199,044 shares of Enovix common stock.
This total includes 153,082 shares that may be issued upon the vesting and settlement of RSUs and 4,978 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each performance RSU represents a contingent right to receive one share of common stock upon settlement.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported a stock transaction dated December 14, 2025. The filing shows that 7,338 shares of common stock were withheld at $8.64 per share to cover tax withholding obligations triggered by the vesting of restricted stock units on that date.
After this transaction, Marathe is reported to beneficially own 980,535 shares of Enovix common stock. This total includes 727,116 shares issuable upon the vesting and settlement of RSUs and 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the other half on March 1, 2027, each PRSU representing the right to receive one share upon settlement.
Enovix Corp officer Kristina Truong reported a routine equity compensation event. On December 10, 2025, 252 shares of Enovix common stock were withheld at a price of $9.13 per share to satisfy tax withholding obligations tied to the vesting of restricted stock units.
After this transaction, she beneficially owns 200,057 shares of Enovix common stock. This includes 154,998 shares issuable upon the vesting and settlement of RSUs and 4,978 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027.
Enovix Corp (ENVX) reported an insider equity transaction by its Chief Accounting Officer, Kristina Truong. On November 21, 2025, she received 3,833 shares of common stock through a fully vested restricted stock unit (RSU) award, serving as her bonus for the quarter ended September 28, 2025. Each RSU converts into one share of Enovix common stock.
To cover tax withholding related to this RSU award, 2,026 shares of common stock were withheld and disposed of at a price of $7.47 per share. After these transactions, Truong beneficially owned 200,309 shares of Enovix common stock, including shares issuable from outstanding RSUs and vested performance RSUs scheduled for release in March 2026 and March 2027.
Enovix Corporation (ENVX) reported insider equity activity for its Chief Legal Officer, Arthi Chakravarthy. On November 21, 2025, she received 4,960 shares of common stock at a price of $0, issued upon the receipt of fully vested restricted stock units (RSUs) earned as bonus for the quarter ended September 28, 2025, with each RSU equal to one share.
To cover tax withholding on RSU vesting, 2,622 shares were withheld on November 21, 2025 at $7.47 per share and 2,217 shares were withheld on November 24, 2025 at $7.58 per share. Following these transactions, Chakravarthy beneficially owned 424,156 shares, including 303,276 shares issuable from RSUs and 20,786 vested performance RSUs scheduled for releases in March 2026 and March 2027.
Enovix Corporation (ENVX) Chief Operating Officer Ajay Marathe reported equity award activity in company stock. On November 21, 2025, he received 6,035 shares of common stock at $0, issued upon the vesting of restricted stock units that represented his bonus for the quarter ended September 28, 2025.
On the same date, 3,190 shares were withheld at a price of $7.47 to cover tax obligations tied to the RSU vesting. After these transactions, Marathe beneficially owned 989,363 shares of Enovix common stock, including large amounts issuable from previously granted RSUs and vested performance RSUs scheduled for release in 2026 and 2027.
Enovix Corp (ENVX) reported a routine insider equity transaction by its Chief Financial Officer. On November 21, 2025, the reporting person received 5,729 shares of common stock through a fully vested restricted stock unit (RSU) award that served as a bonus for the quarter ended September 28, 2025, at a stated price of $0 per share. On the same date, 3,028 shares of common stock were withheld at $7.47 per share to cover tax obligations related to this RSU vesting. After these transactions, the reporting person beneficially owned 753,690 shares of Enovix common stock, including 748,752 shares issuable upon settlement of previously granted RSUs.
Enovix Corporation (ENVX) reported insider equity activity by its President and CEO, who is also a director. On November 21, 2025, the executive received 9,427 shares of common stock at $0, issued upon the vesting of restricted stock units (RSUs) that represent bonus awards for the quarter ended September 28, 2025. On the same date, 4,983 shares were withheld at a price of $7.47 to cover tax obligations tied to this RSU vesting.
Following these transactions, the executive beneficially owned 2,298,829 shares of Enovix common stock on a direct basis. This total includes 1,674,293 shares underlying RSUs and 95,551 vested performance RSUs (PRSUs), with half of the PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each RSU or PRSU represents the right to receive one share of common stock.